Shilpa Medicare facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (Andhra Pradesh) has become operational.
The company’s new facility is to take up for Contract Research and Forward Integration, that is, own formulation (manufacturing of oral and injectible (for onco products).
“Facility for manufacture of formulation section will commence commercial production in stages after successful completion of trial production/stability tests which is under way,” a senior company official said.
The company had visualised contract research as one of the thrust area few years back. It invested in creating research and development centres at two places.
Such investment has started yielding results. It expects that this will grow in time to come and would become an important source of income, besides inventing new/improved products for the company.